Prohibits health insurance providers from requiring preauthorization for in-network mental health or substance use disorder services.
Prohibits health insurance providers from requiring preauthorization for in-network mental health or substance use disorder services.
Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2025.
Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2025.
Defines step therapy and prohibits certain groups and agreements from requiring prior authorization or a step therapy protocol when prescribing certain medications.
Prohibits prior authorization or a step therapy protocol for the prescription of a nonpreferred medication on their drug formulary used to assess or treat an enrollee's bipolar disorder, schizophrenia or schizotypal.
Requires insurance coverage for at a minimum up to ninety (90) days of residential or inpatient services for mental health and/or substance use disorders for American Society of Addiction Medicine levels of care 3.1 and 3.3.
Requires insurance coverage for at a minimum up to ninety (90) days of residential or inpatient services for mental health and/or substance use disorders for American Society of Addiction Medicine levels of care 3.1 and 3.3.
Eliminates prior authorization or step therapy requirement for prescriptions for any HIV prevention drug/prohibits the requirement of any copayment or the meeting of any deductible to obtain the prescription covered by the contract, plan, or policy.
Eliminates prior authorization or step therapy requirement for prescriptions for any HIV prevention drug/prohibits the requirement of any copayment or the meeting of any deductible to obtain the prescription covered by the contract, plan, or policy.